Systemic exposure of pimecrolimus cream 1% and tacrolimus ointment 0.1% in adult patients with moderate to severe atopic dermatitis

被引：3
|
作者：
Draelos, ZD
Hanifin, J
Chon, K
机构：
[1] Dermatol Consulting Serv, High Point, NC USA
[2] Oregon Hlth Sci Univ, Dept Dermatol, Portland, OR 97201 USA
[3] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 03期
关键词：
D O I：
10.1016/j.jaad.2003.10.019
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P13
引用
收藏
页码：P4 / P4
页数：1
相关论文
共 50 条
  • [41] Pimecrolimus cream 1% in the long term management of severe adult atopic eczema
    Meurer, M.
    Braeutigam, M.
    EADV: PROCEEDINGS OF THE 15TH CONGRESS OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, : 429 - +
  • [42] Steroid-sparing effect of pimecrolimus cream 1% in children with severe atopic dermatitis
    Zuberbier, Torsten
    Heinzerling, Lucie
    Bieber, Thomas
    Schauer, Uwe
    Klebs, Sven
    Braeutigam, Matthias
    DERMATOLOGY, 2007, 215 (04) : 325 - 330
  • [43] Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, Safety
    Soter, NA
    Fleischer, AB
    Webster, GF
    Monroe, E
    Lawrence, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (01) : S39 - S46
  • [44] Tacrolimus pharmacokinetics in adult and pediatric atopic dermatitis patients following topical application of tacrolimus ointment
    Krueger, G
    Eichenfield, L
    Holum, ME
    Keirns, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB88 - AB88
  • [45] PHARMACOKINETICS OF TACROLIMUS FOLLOWING TOPICAL APPLICATION OF TACROLIMUS OINTMENT IN ADULT AND PAEDIATRIC PATIENTS WITH ATOPIC DERMATITIS
    Undre, N. A.
    ACTAS DERMO-SIFILIOGRAFICAS, 2008, 99 : 2 - 7
  • [46] Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis
    Meurer, M
    Fartasch, M
    Albrecht, G
    Vogt, T
    Worm, M
    Ruzicka, T
    Altmeyer, PJ
    Schneider, D
    Weidinger, G
    Braeutigam, M
    DERMATOLOGY, 2004, 208 (04) : 365 - 372
  • [47] Comparative pharmacokinetics of topical tacrolimus cream 0.03% with cream 0.01% and ointment 0.03% in adults and with ointment 0.03% in pediatric patients with atopic dermatitis
    Jones, T
    Apseloff, G
    Carter, E
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P68 - P68
  • [48] Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, Efficacy
    Hanifin, JM
    Ling, MR
    Langley, R
    Breneman, D
    Rafal, E
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (01) : S28 - S38
  • [49] Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis
    Daehnhardt-Pfeiffer, Stephan
    Daehnhardt, Dorothee
    Buchner, Matthias
    Walter, Kersten
    Proksch, Ehrhardt
    Foelster-Holst, Regina
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (05): : 437 - 444
  • [50] The effects of pimecrolimus cream 1% on key physiology parameters in patients with atopic dermatitis
    Aschoff, R.
    Schwanebeck, U.
    Braeutigam, M.
    Meurer, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S102 - S102
12345